Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q79745346)
Watch
English
Chemotherapy for advanced non-small cell lung cancer
scientific article published on 01 February 2004
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Chemotherapy for advanced non-small cell lung cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
main subject
non-small-cell lung carcinoma
1 reference
based on heuristic
inferred from title
author name string
Sarita Dubey
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
Joan H Schiller
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
publication date
1 February 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
published in
Hematology / Oncology Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
volume
18
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
issue
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
page(s)
101-114
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
cites work
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Onc
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma .
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900135-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0889-8588(03)00135-7
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
PubMed ID
15005284
1 reference
stated in
Europe PubMed Central
PubMed ID
15005284
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005284%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit